Regdanvimab - CAS 2444308-95-4

Regdanvimab (CT-P59) is a humanized antibody targeting the spike protein of SARS-CoV-2, with antiviral activity. It prevents viral entry by blocking interactions with ACE2, used in studies of COVID-19 infection.

RAAS, SARS-CoV, Angiotensin-converting Enzyme (ACE)

Endocrinology/Hormones, Metabolism, Microbiology/Virology

2444209

1

-20°C

Ice Packs

Inhibitory Antibodies